Supply Issues ICU Medical International Ltd Paediatric Endotracheal Tubes (ICN 2759)

Change:

• The supplier ICU Medical International Ltd has informed us of a supply issue with its Paediatric Endotracheal Tubes.
• There are 10 product codes affected.
• The supply issue is due to a global ship hold; further information is to be provided shortly.

Impact:

• Due to this ongoing supply issue, six products codes are now being threshold managed as they are subject to Protect Demand Management:
  • FDF168, FDF264, FDF265, FDF276, FDF280 and FDF283.
• These products are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Four product codes are currently suspended and unavailable to order:
  • FDF1262, FDF1261, FDF017 and FDF048.
• Potential indirect alternative products are available to order through our online catalogue.
• We are currently sourcing further stocked alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• We do not currently have a resolution date for the supply issue and will update this ICN as soon as we have further information.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.